NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
NEUTRA CORP.
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Neutra has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Neutra filed with the SEC
FORM 8-K FOR 05-03-2024
Event dated May 3, 2024, from SEC EDGAR
FORM 8-K FOR 08-01-2023
Event dated Aug 1, 2023, from SEC EDGAR
FORM 8-K CURRENT REPORT FOR 07-09-2020
Event dated Jul 9, 2020, from SEC EDGAR
FORM 8-K CURRENT REPORT FOR 06-15-2020
Event dated Jun 15, 2020, from SEC EDGAR
FORM 8-K CURRENT REPORT FOR 04-30-2020
Event dated Apr 30, 2020, from SEC EDGAR
FORM 8-K CURRENT REPORT FOR 10-07-2019
Event dated Oct 7, 2019, from SEC EDGAR
FORM 8-K CURRENT REPORT FOR 09-06-2019
Event dated Sep 6, 2019, from SEC EDGAR
FORM 8-K CURRENT REPORT FOR 04-24-2019
Event dated Apr 24, 2019, from SEC EDGAR